These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38926853)

  • 1. Enhancer engagement sustains oncogenic transformation and progression of B-cell precursor acute lymphoblastic leukemia.
    Corleone G; Sorino C; Caforio M; Di Giovenale S; De Nicola F; Goeman F; Bertaina V; Pitisci A; Cortile C; Locatelli F; Folgiero V; Fanciulli M
    J Exp Clin Cancer Res; 2024 Jun; 43(1):179. PubMed ID: 38926853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia.
    Jakobczyk H; Debaize L; Soubise B; Avner S; Rouger-Gaudichon J; Commet S; Jiang Y; Sérandour AA; Rio AG; Carroll JS; Wichmann C; Lie-A-Ling M; Lacaud G; Corcos L; Salbert G; Galibert MD; Gandemer V; Troadec MB
    J Hematol Oncol; 2021 Mar; 14(1):47. PubMed ID: 33743795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?
    Dyer MJ; Akasaka T; Capasso M; Dusanjh P; Lee YF; Karran EL; Nagel I; Vater I; Cario G; Siebert R
    Blood; 2010 Feb; 115(8):1490-9. PubMed ID: 20042721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRMT5-mediated H4R3sme2 Confers Cell Differentiation in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia.
    Mei M; Zhang R; Zhou ZW; Ying Z; Wang J; Zhang H; Zheng H; Bao S
    Clin Cancer Res; 2019 Apr; 25(8):2633-2643. PubMed ID: 30635341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA gene methylation landscape in pediatric B-cell precursor acute lymphoblastic leukemia.
    Chaber R; Gurgul A; Tabarkiewicz J; Wróbel G; Szmatoła T; Jasielczuk I; Haus O; Lejman M; Rybka B; Ryczan-Krawczyk R; Jaśkowiec A; Paszek S; Potocka N; Arthur CJ; Bal W; Łach K; Kowal A; Zawlik I; Latos-Grażyńska E
    Adv Clin Exp Med; 2022 Mar; 31(3):293-305. PubMed ID: 35092653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low expression of
    Cui L; Gao C; Wang CJ; Liu SG; Wu MY; Zhang RD; Li ZG
    Pediatr Hematol Oncol; 2020 Nov; 37(8):732-746. PubMed ID: 32804017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNAs in B-cell development and activation.
    Brazão TF; Johnson JS; Müller J; Heger A; Ponting CP; Tybulewicz VL
    Blood; 2016 Aug; 128(7):e10-9. PubMed ID: 27381906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer.
    Wang E; Kawaoka S; Roe JS; Shi J; Hohmann AF; Xu Y; Bhagwat AS; Suzuki Y; Kinney JB; Vakoc CR
    Elife; 2015 Apr; 4():e06377. PubMed ID: 25919951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique long non-coding RNA expression signature in ETV6/RUNX1-driven B-cell precursor acute lymphoblastic leukemia.
    Ghazavi F; De Moerloose B; Van Loocke W; Wallaert A; Helsmoortel HH; Ferster A; Bakkus M; Plat G; Delabesse E; Uyttebroeck A; Van Nieuwerburgh F; Deforce D; Van Roy N; Speleman F; Benoit Y; Lammens T; Van Vlierberghe P
    Oncotarget; 2016 Nov; 7(45):73769-73780. PubMed ID: 27650541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
    James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
    J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan.
    Sakaguchi K; Imamura T; Ishimaru S; Imai C; Shimonodan H; Fujita N; Okada K; Taketani T; Kanai R; Tauchi H; Kato M; Kojima Y; Watanabe A; Deguchi T; Hashii Y; Kiyokawa N; Taki T; Saito AM; Horibe K; Manabe A; Sato A; Koh K
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28341. PubMed ID: 32323914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed gene dose analysis reveals recurrent focal gene deletions in pediatric B-cell precursor acute lymphoblastic leukemia.
    Ivanov Öfverholm I; Tran AN; Olsson L; Zachariadis V; Heyman M; Rudd E; Syk Lundberg E; Nordenskjöld M; Johansson B; Nordgren A; Barbany G
    Leuk Lymphoma; 2016 Sep; 57(9):2161-70. PubMed ID: 27090575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia.
    Folgiero V; Sorino C; Pallocca M; De Nicola F; Goeman F; Bertaina V; Strocchio L; Romania P; Pitisci A; Iezzi S; Catena V; Bruno T; Strimpakos G; Passananti C; Mattei E; Blandino G; Locatelli F; Fanciulli M
    EMBO Rep; 2018 Mar; 19(3):. PubMed ID: 29367285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
    Pi WC; Wang J; Shimada M; Lin JW; Geng H; Lee YL; Lu R; Li D; Wang GG; Roeder RG; Chen WY
    Blood; 2020 Jul; 136(1):11-23. PubMed ID: 32276273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia.
    Wang H; Sun H; Liang B; Zhang F; Yang F; Cui B; Ding L; Wang X; Wang R; Cai J; Tang Y; Rao J; Hu W; Zhao S; Wu W; Chen X; Wu K; Lai J; Xie Y; Li B; Tang J; Shen S; Liu Y
    Nat Commun; 2023 Oct; 14(1):6792. PubMed ID: 37880218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming Microenvironment-Mediated Chemoprotection through Stromal Galectin-3 Inhibition in Acute Lymphoblastic Leukemia.
    Tarighat SS; Fei F; Joo EJ; Abdel-Azim H; Yang L; Geng H; Bum-Erdene K; Grice ID; von Itzstein M; Blanchard H; Heisterkamp N
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression.
    Huang M; Inukai T; Miyake K; Tanaka Y; Kagami K; Abe M; Goto H; Minegishi M; Iwamoto S; Sugihara E; Watanabe A; Somazu S; Shinohara T; Oshiro H; Akahane K; Goi K; Sugita K
    Cancer Med; 2018 Apr; 7(4):1297-1316. PubMed ID: 29473342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inferring a role for methylation of intergenic DNA in the regulation of genes aberrantly expressed in precursor B-cell acute lymphoblastic leukemia.
    Almamun M; Kholod O; Stuckel AJ; Levinson BT; Johnson NT; Arthur GL; Davis JW; Taylor KH
    Leuk Lymphoma; 2017 Sep; 58(9):1-12. PubMed ID: 28094574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles.
    Oh L; Hainaut P; Blanchet S; Ariffin H
    BMC Cancer; 2020 Feb; 20(1):110. PubMed ID: 32041553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.
    Russell LJ; Capasso M; Vater I; Akasaka T; Bernard OA; Calasanz MJ; Chandrasekaran T; Chapiro E; Gesk S; Griffiths M; Guttery DS; Haferlach C; Harder L; Heidenreich O; Irving J; Kearney L; Nguyen-Khac F; Machado L; Minto L; Majid A; Moorman AV; Morrison H; Rand V; Strefford JC; Schwab C; Tönnies H; Dyer MJ; Siebert R; Harrison CJ
    Blood; 2009 Sep; 114(13):2688-98. PubMed ID: 19641190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.